Operating Company Healthcare

Emmes

Rockville, Maryland, United States

Formerly known as Emmes Company, LLC, Emmes Group, The Emmes Company

Emmes is a global full-service contract research organization (CRO) providing clinical research services, including clinical trial management, biostatistics, data management/bioinformatics, and regulatory support for public health and biopharmaceutical innovation.

Focus Areas
Clinical Research Organization (CRO), Biostatistics, Data Management

Tracked deals

7

7 tracked deals across 2020-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

4 addon · 3 buyout

Emmes Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for Emmes. 1 2020 2 2021 2 2022 2 2023

Supporting Data

Recent Transactions

  • Emmes Acquires VaxTRIALS
    October 4, 2023
    Buyer
    Emmes
    Target
    VaxTRIALS
    Industry
    Healthcare Services
    Location
    Panama Province, Panama
    Type
    Buyout

    Emmes, a global full-service Contract Research Organization (CRO) based in Rockville, Maryland, has acquired VaxTRIALS, a Panama City–headquartered CRO specializing in vaccine clinical trials with 160+ staff across Latin America. The acquisition expands Emmes' geographic footprint into Latin America and strengthens its vaccine and infectious disease clinical trial capabilities.

  • Emmes Acquires Essex Management
    March 21, 2023
    Buyer
    Emmes
    Target
    Essex Management
    Industry
    Healthcare Services
    Location
    Maryland, United States
    Type
    Buyout

    Emmes, a global full-service clinical research organization, acquired Essex Management, a bioinformatics and health information technology consultancy, to enhance Emmes' data, bioinformatics and HIT capabilities. The acquisition adds more than 100 employees and expands Emmes' ability to serve government, academic and biopharma clients, including continued support for the National Cancer Institute.

  • Emmes Acquires Clinical Edge
    September 28, 2022
    Buyer
    Emmes
    Target
    Clinical Edge
    Industry
    Healthcare Services
    Location
    Wisconsin, United States
    Type
    Buyout

    Emmes, a global full-service clinical research organization, has acquired Clinical Edge, a Milwaukee-based provider of visual function examiner training and certification for ophthalmic clinical trials. The deal combines Clinical Edge with Emmes' Optym ophthalmology unit (rebranded OptymEdge), expanding Emmes' ophthalmology certification capabilities and geographic reach across the U.S., Europe and Asia.

  • Emmes Acquires Casimir to Strengthen Rare Disease Research Capabilities
    May 10, 2022
    Buyer
    Emmes, Behrman Capital
    Target
    Casimir
    Industry
    Healthcare Services
    Location
    Massachusetts, United States
    Type
    Addon

    Emmes, a portfolio company of Behrman Capital, has acquired Casimir, a Plymouth, Massachusetts–based CRO specializing in rare disease outcome measures and virtual/remote assessments. The add-on expands Emmes' rare disease center of excellence and brings Casimir's clinical outcomes technology and expertise into Emmes' global service offerings; terms were not disclosed.

  • Emmes Acquires Institut Dr. Schauerte
    December 21, 2021
    Buyer
    Emmes, Behrman Capital
    Target
    Institut Dr. Schauerte
    Industry
    Healthcare Services
    Location
    Bavaria, Germany
    Type
    Addon

    Emmes, a Behrman Capital portfolio company, has acquired Institut Dr. Schauerte (IDS), a Munich- and Cottbus-based clinical research organization specializing in late-phase, non-interventional and post-market studies. The add-on expands Emmes' European footprint and Real World Evidence capabilities; with IDS the Emmes organization surpasses 1,200 employees.

  • Emmes Acquires UK-Based Orphan Reach
    May 11, 2021
    Buyer
    Emmes, Behrman Capital
    Target
    Orphan Reach
    Industry
    Healthcare Services
    Location
    England, United Kingdom
    Type
    Addon

    Emmes, a global full-service CRO and portfolio company of Behrman Capital, acquired Orphan Reach, a UK-based CRO specialized in rare-disease clinical research. The add-on expands Emmes' geographic footprint and rare-disease capabilities; Orphan Reach's founder and management will remain in place and financial terms were not disclosed.

  • Emmes Acquires Neox
    December 30, 2020
    Buyer
    The Emmes Company, LLC, Behrman Capital
    Target
    Neox S.R.O.
    Industry
    Healthcare Services
    Location
    Prague, Czech Republic
    Type
    Addon

    The Emmes Company, a Behrman Capital portfolio company, has acquired Prague-headquartered CRO Neox S.R.O., an add-on that expands Emmes' BioPharma capabilities and Central/Eastern European presence. Financial terms were not disclosed; Neox brings over 150 employees and operations across multiple European countries, and founders Pavel and Petr Marek will remain in leadership roles.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 7 tracked deals by Emmes. Acquisitions in Maryland 1 tracked deal by Emmes. Acquisitions in Massachusetts 1 tracked deal by Emmes. Acquisitions in Wisconsin 1 tracked deal by Emmes.

Related articles

Selling a company? Get in front of buyers like Emmes

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →